Cell transplantation as an initiator of endogenous stem cell-based tissue repair

Current Opinion in Organ Transplantation

Volumn 17, Issue 6, 2012, Pages 670-674

  Dong, Feng ^a   Caplan, Arnold I ^b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

cell transplantation; endogenous stem cell; tissue repair

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1ALPHA;

CELL ACTIVATION; CELL AGING; CELL FUNCTION; CELL HOMING; CELL REGENERATION; CYTOKINE RELEASE; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROENVIRONMENT; NONHUMAN; REVIEW; STEM CELL TRANSPLANTATION; TISSUE INJURY; TISSUE REPAIR;

CELL TRANSPLANTATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; WOUND HEALING;

EID: 84870250684     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328359a617     Document Type: Review

References (32)

1. Dong F, Harvey J, Finan A, et al. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation 2012; 126:314-324.
2. Chen FM, Wu LA, Zhang M, et al. Homing of endogenous stem/progenitor cells for in situ tissue regeneration: promises, strategies, and translational perspectives. Biomaterials 2011; 32:3189-3209.
3. Penn MS, Dong F, Klein S, Mayorga ME. Stem cells for myocardial regeneration. Clin Pharmacol Ther 2011; 90:499-501.
4. Carr CA, Stuckey DJ, Tan JJ, et al. Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks an MRI study. PLoS One 2011; 6:e25669.
5. Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5:54-63.
6. Bieback K, Brinkmann I. Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells 2010; 2:81-92.
7. Usas A, Maciulaitis J, Maciulaitis R, et al. Skeletal muscle-derived stem cells: implications for cell-mediated therapies. Medicina (Kaunas) 2011; 47:469-479.
8. Colnot C. Cell sources for bone tissue engineering: insights from basic science. Tissue Eng Part B Rev 2011; 17:449-457.
9. Lee CH, Cook JL, Mendelson A, et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 2010; 376:440-448.
10. Finan A, Kiedrowski M, Turturice BA, et al. Cardiac pressure overload initiates a systemic stem cell response. Cytotherapy 2012; 14:983-993.
11. Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007; 21:3197-3207. (Pubitemid 47565538)
12. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011; 9:11-15.
13. Lee BC, Hsu HC, Tseng WY, et al. Cell therapy generates a favorable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits. Eur J Heart Fail 2009; 11:238-245.
14. Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med 2011; 15:1032-1043.
15. Zaruba MM, Theiss HD, Vallaster M, et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009; 4:313-323.
16. Jungraithmayr W, De Meester I, Matheeussen V, et al. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg 2012; 41:1166-1173.
17. Misra P, Lebeche D, Ly H, et al. Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. J Nucl Med 2008; 49:963-969. (Pubitemid 351793437)
18. Krankel N, Spinetti G, Amadesi S, Madeddu P. Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol Ther 2011; 129:62-81.
19. Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intra-coronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol 2011; 58:977-986.
20. Osugi M, Katagiri W, Yoshimi R, et al. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A 2012; 18:1479-1489.
21. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 2011; 6:457-478.
22. Joyce N, Annett G, Wirthlin L, et al. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010; 5:933-946.
23. Forteza R, Casalino-Matsuda SM, Monzon ME, et al. TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release. Am J Respir Cell Mol Biol 2007; 36:20-31. (Pubitemid 46067704)
24. Schenk S, Mal N, Finan A, et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007; 25:245-251. (Pubitemid 46052996)
25. Yang J, Aguila JR, Alipio Z, et al. Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4. J Hematol Oncol 2011; 4:38.
26. Wang Y, Cheng X, He Q, et al. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci 2011; 31:6053-6058.
27. Baiu D, Merriam F, Odorico J. Potential pathways to restore beta-cell mass: pluripotent stem cells, reprogramming, and endogenous regeneration. Curr Diab Rep 2011; 11:392-401.
28. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007; 117:2553-2561. (Pubitemid 47494356)
29. Chistiakov DA. Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation. J Biomed Sci 2010; 17:92.
30. Caplan AI, Correa D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res 2011; 29:1795-1803.
31. Wernicke CM, Grunewald TG, Juenger H, et al. Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases. Int Arch Med 2011; 4:27.
32. Zwi-Dantsis L, Huber I, Habib M, et al. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. Eur Heart J 2012. [Epub ahead of print]